Christopher B Capel

Practice Areas

Extensive experience over 40 years advising emerging and established companies, both privately and publicly held, in corporate, securities, and technology law matters. Practice emphasizes mergers, acquisitions and divestitures; intellectual property licensing, collaborations and transfers; strategic alliances/collaborations/joint-ventures/corporate partnering; funding/financing/investment transactions; public and private securities offerings; public company compliance; corporate governance; international transactions. Includes focus on pharmaceutical, biotech, medical device and other life sciences and agtech transactions.

Career

Since 1990: Smith Anderson. 1986-90: White & Case, LLP, New York NY. 1985-86: Judicial Law Clerk to Sam J. Ervin, III, U.S. Court of Appeals, Fourth Circuit. 1979-82: Wachovia Bank, Commercial Banker.

Professional Memberships

North Carolina Bar (1985); New York Bar (1987). Member of American, NC, and NY Bar Associations. Past Chair, Business Law Section of NC Bar Association. Listed: Chambers USA, Corporate/M&A (2006-2024); The Best Lawyers in America ("Lawyer of the Year" Raleigh/Research Triangle market: 2020 in Securities Regulation; 2024/2019/2017/2014 in Securities/Capital Markets; 2010 in Mergers & Acquisitions); also listed in Best Lawyers for Biotechnology Law, Corporate Law, M&A, Securities/Capital Markets, Securities Regulation, Venture Capital; IFLR1000: M&A.

Board of Directors, North Carolina Life Sciences Organization (NC Life Sci).

Personal

JD (honors) and Law Review, University of North Carolina School of Law, 1985; BA Economics, University of North Carolina at Chapel Hill, 1979.